Chintu Patel - Dec 15, 2021 Form 4 Insider Report for Amneal Pharmaceuticals, Inc. (AMRX)

Signature
/s/ Meredith Cook, Attorney-in-Fact
Stock symbol
AMRX
Transactions as of
Dec 15, 2021
Transactions value $
$625,500
Form type
4
Date filed
12/17/2021, 03:15 PM
Next filing
Mar 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMRX Class A Common Stock Purchase $413K +100K +27.58% $4.13 463K Dec 15, 2021 Direct F1
transaction AMRX Class A Common Stock Purchase $213K +50K +10.81% $4.25 513K Dec 16, 2021 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.06 to $4.18. The reporting person undertakes to provide Amneal Pharmaceuticals, Inc. (the "Company"), any security holder of the Company, or of the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.20 to $4.30. The reporting person undertakes to provide the Company, any security holder of the Company, or of the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.